Latest Articles

  • Lung cancer screening: One step forward
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 306; DOI: https://doi.org/10.3949/ccjm.79b.12005

    I never expected, perhaps naively, that cancer screening would be so challenging and contentious.

  • Locally advanced non–small cell lung cancer: What is the optimal concurrent chemoradiation regimen?
    Gregory M.M. Videtic, MD, CM, FRCPC
    Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S32-S37; DOI: https://doi.org/10.3949/ccjm.79.s2.07
  • Treatment implications of the new lung cancer staging system
    Cristina P. Rodriguez, MD
    Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S7-S10; DOI: https://doi.org/10.3949/ccjm.79.s2.02
  • A geriatric patient-centered medical home: How to obtain NCQA certification
    Amelia Gennari, MD, Kim Fedor, BSN, MBA, Eric Bakow, MA, MPM, RRT and Neil M. Resnick, MD
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 359-366; DOI: https://doi.org/10.3949/ccjm.79a.11103

    Applying for certification is hard work but, if accompanied by real changes to your practice, should improve the care you deliver.

  • The rationale for, and design of, a lung cancer screening program
    Peter Mazzone, MD, MPH and
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 337-345; DOI: https://doi.org/10.3949/ccjm.79a.12018

    We are entering a new era in which lung cancer screening may be considered the standard of care.

  • Correction
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 312;

    An error appeared in “Advances in the management of PML: focus on natalizumab” (Fox R. Cleve Clin J Med 2011; 78[suppl 2]:S33–S37).

  • Should I order an anti-CCP antibody test to diagnose rheumatoid arthritis?
    Nilanjana Bose, MD and Leonard H. Calabrese, DO
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 249-252; DOI: https://doi.org/10.3949/ccjm.79a.11008

    This test is highly specific, though it may be redundant for a patient who has documented rheumatoid arthritis and who is seropositive for rheumatoid factor.

  • Parkinson disease (January 2012)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242-243; DOI: https://doi.org/10.3949/ccjm.79c:04006

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04004

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • A nodule on a woman’s face
    Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD, Antonio Cutando, PhD, Agustín Buendía-Eisman, PhD, Ramón Naranjo-Sintes, PhD, Antonio Campos, PhD and Miguel Alaminos-Mingorance
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 282-284; DOI: https://doi.org/10.3949/ccjm.79a.10115

    It is firm, pink, 10 mm in diameter, with surrounding telangiectasias. What is it?

Pages